Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis

N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis

US Patent 12358875 · Granted Jul 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NLRP3 modulators2025
NLRP3 modulators2025
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides2024
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides2024
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides2024
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides2024
NLRP3 modulators2024
NLRP3 modulators2024
Substituted alkoxypyridinyl indolsulfonamides2024
Pyridinyl and pyrazinyl-(asa)indolsulfonamides2024
Pyridinyl and pyrazinyl-(asa)indolsulfonamides2024
Pyridinyl and pyrazinyl-(asa)indolsulfonamides2024